Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Total 13F shares
-
40,270,330
-
Share change
-
-2,881,569
-
Total reported value
-
$126,445,664
-
Put/Call ratio
-
46%
-
Price per share
-
$3.14
-
Number of holders
-
111
-
Value change
-
-$13,890,439
-
Number of buys
-
53
-
Number of sells
-
56
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q3 2023
As of 30 Sep 2023 OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) had 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 40,270,330 shares of stock of the company.
Largest 10 holders included Opaleye Management Inc., SUMMER ROAD LLC, BlackRock Inc., VANGUARD GROUP INC, DELTEC ASSET MANAGEMENT LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, Nuveen Asset Management, LLC, and SECTORAL ASSET MANAGEMENT INC.
This table shows 112 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.